Home
Conditions
Large B-cell Lymphoma

Clinical trial condition

Large B-cell Lymphoma

Explore clinical trials studying Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

60 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Large B-cell Lymphoma trial results

Not Yet Recruiting

Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas

NCT07608731

Conditions: Central Nervous System Lymphoma, Large B-cell Lymphoma
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Not Yet Recruiting

LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure

NCT07602322

Conditions: Large B-cell Lymphoma
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases

NCT06567080

Conditions: Autoimmune Diseases, B-cell Tumors, Connective Tissue Diseases, +4 more
Locations: Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

View Trial Details

Not Yet Recruiting

CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors

NCT06567366

Conditions: Large B-cell Lymphoma
Locations: Shanghai Ruijin Hospital Shanghai, China

View Trial Details

Not Yet Recruiting

Relmacabtagene Autoleucel in Hematologic Malignancies

NCT06142188

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Peking University International Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT

NCT07236151

Conditions: Auto Stem Cell Transplant, CAR T Cell Therapy, Large B-cell Lymphoma
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Completed

CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma

NCT04690192

Conditions: Large B-cell Lymphoma
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Completed

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

NCT04566978

Conditions: DLBCL, Large B-cell Lymphoma
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting

NCT05108805

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Active, Not Recruiting

Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies

NCT05665062

Conditions: CLL/SLL, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +17 more
Locations: City of Hope Duarte, California, United States

Roswell Park Buffalo, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Large B-cell Lymphoma

Large B-cell Lymphoma trial results

Related conditions